NCT00573690View on ClinicalTrials.gov

Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

February 28, 2011

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

carboplatin

Given IV

DRUG

cisplatin

Given IV

DRUG

etoposide

Given IV

DRUG

pemetrexed disodium

Given IV

DRUG

sorafenib tosylate

Given orally

Trial Locations (1)

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT00573690 - Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter